# Cellular fats and cultured lipids

True animal cell culture — growing adipose (fat) cells rather than fermenting a microbial host — reached a first regulatory milestone in 2025 when Mission Barns won USDA and FDA sign-off for cultivated pork fat, even as a UK cell-culture originator went into administration.

Source: https://en.bioecon.ru/technology/cellular-fats-cultured-lipids/
Updated: 2026-08-18



## Overview and value chain

Markers: [EC: USDA/FDA joint regulatory framework for cell-cultured animal products | OECD: Food systems | Regulator: FDA (USA)]

Cellular fats and cultured lipids grow actual animal adipose-derived cells
— not a fermenting microbe standing in for animal fat — to produce a
cultivated fat ingredient that blends into hybrid meat and plant-based
products. Mission Barns won USDA and FDA sign-off for cultivated pork fat in
2025 and is targeting a Sprouts Farmers Market launch, using a proprietary
bioreactor design intended to lower the capital intensity that has slowed
whole-cut cultivated meat. Because fat cells are used as a flavor- and
texture-carrying ingredient rather than a full-tissue meat replacement, the
category needs far less structural scaffolding than whole-muscle cultivated
meat, and academic groups have demonstrated proof-of-concept adipose-derived
stem cell fat production from both bovine and duck cell lines in 3D culture.
The category has already produced its own cautionary tale: CellulaREvolution,
a UK originator working on bovine adipose-derived stem cell spheroids as
building blocks for cultured fat, entered administration, with its IP and
assets put up for sale.

Key directions of cellular fats and cultured lipids:
1. **Cultivated pork/duck fat (Cultivated Pork/Duck Fat):** adipose-derived
   cells grown and harvested specifically as a fat ingredient for blended
   meat products, proven at lab scale for both pork and duck cell lines.
2. **Ingredient-scale cell culture (Ingredient-Scale Cell Culture):** fat
   cells cultured as a flavor/texture additive rather than attempting a
   full structural meat replacement, lowering the scaffolding and bioreactor
   burden versus whole-cut cultivated meat.
3. **Novel bioreactor engineering for fat cells (Novel Bioreactor
   Engineering for Fat Cells):** purpose-built, more easily scaled
   bioreactor designs specifically targeting fat-cell culture economics
   rather than adapting muscle-cell bioreactors.
4. **3D spheroid biofabrication (3D Spheroid Biofabrication):** building
   cultured fat from dynamically cultured, differentiated adipose-derived
   stem cell spheroids as a structural building block.

### Sectoral value chain

```
[cell line sourcing] ──> [growth-media formulation] ──> [bioreactor cultivation] ──> [fat harvest & processing]
                                                                 │
                                                         (regulatory
                                                          clearance)
                                                                 │
                                                                 ▼
[hybrid meat product] <─── [ingredient blending] <──────────────┘
```

### Value chain levels

| Level | Description | Key inputs/outputs |
|:---|:---|:---|
| **Cell Line Sourcing** | isolating adipose-derived stem cells from a target species | **In:** biopsy/cell bank source. **Out:** adipose-derived cell line. |
| **Growth-Media Formulation** | formulating serum-free media to differentiate and expand fat cells | **In:** nutrient inputs. **Out:** differentiation-ready medium. |
| **Bioreactor Cultivation** | growing fat cells or spheroids at scale in purpose-built bioreactors | **In:** cell line, medium. **Out:** cultured fat biomass. |
| **Fat Harvest & Processing** | separating and processing cultured fat into a usable ingredient | **In:** cultured fat biomass. **Out:** cultivated fat ingredient. |
| **Regulatory Clearance** | USDA/FDA joint pre-market review for a cell-cultured food ingredient | **In:** safety dossier. **Out:** market authorization. |
| **Ingredient Blending** | blending cultivated fat into a hybrid meat or plant-based product | **In:** cleared fat ingredient. **Out:** finished blended product. |

Cross-cutting technologies of the sector:
- **Adipose-derived stem cell isolation (Adipose-Derived Stem Cell Isolation):** sourcing and banking the target species' fat-precursor cells as the production cell line.
- **3D spheroid culture (3D Spheroid Culture):** growing differentiated adipose-derived cells as spheroids to serve as building blocks for structured cultured fat.
- **Purpose-built fat-cell bioreactors (Purpose-Built Fat-Cell Bioreactors):** bioreactor designs engineered specifically around fat-cell (rather than muscle-cell) culture economics.

---

## US

The US hosts the sector's first regulatory-cleared cultivated fat product
and a second cell-agriculture originator founded by an early cultivated-meat
tissue-engineering researcher.

### USDA/FDA joint sign-off, novel bioreactor scale-up, cultivated-meat tissue-engineering pedigree
- **Mission Barns:** won USDA and FDA sign-off for cultivated pork fat in 2025, developed a novel, more easily scaled bioreactor design, and is targeting a retail launch through Sprouts Farmers Market.
- **Ohayo Valley:** founded by Dr. Jess Krieger, one of the first researchers in the world to pursue a PhD specifically on cultivated meat tissue engineering, extending that research background into a cell-agriculture venture.

---

## CN

Public information on a dedicated Chinese cellular-fat/cultured-lipid
originator was not confirmed in this pass; the section stays at the policy
level.

### no confirmed flagship originator, adjacent fermentation-fat investment, regulatory framework absent
- **No confirmed flagship originator:** a Chinese company operating a true animal-cell-culture fat platform (as opposed to microbial-fermentation fat production) was not confirmed via live sources in this pass.
- **Adjacent fermentation-fat activity:** Chinese fermentation specialists have partnered with overseas precision-fermentation fat originators, reflecting capacity and investment interest in fat alternatives generally, without a confirmed domestic cell-culture originator.
- **No dedicated regulatory framework:** unlike the US's USDA/FDA joint review pathway, no China-specific cell-cultured-fat authorization framework was confirmed in this pass.

---

## EU

The EU/UK region shows both a growing cell-cultured-fat originator raising
early funding and a cautionary example of one going into administration.

### Berlin-based cultured-fat funding, UK spheroid biofabrication research, insolvency risk in early-stage cell agriculture
- **Cultimate Foods:** a Berlin-based originator (founded 2022) specializing in cultivating animal fat as an ingredient to improve the flavor and quality of plant-based meat, which raised €2.3 million to develop its fat ingredient.
- **CellulaREvolution:** a UK originator that developed dynamically cultured, differentiated bovine adipose-derived stem cell spheroids as building blocks for biofabricating cultured fat, but entered administration, with its IP and assets subsequently put up for sale.
- **Early-stage capital risk:** the sector's UK example illustrates that cell-culture-based fat ventures carry meaningful insolvency risk at the pre-commercial research stage, distinct from the demand-side risk seen in industrial insect farming.

---

## Leading companies and research institutes

| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|:---|:---|:---|:---|:---|
| **Mission Barns** | 🇺🇸 USA | *Cultivated pork fat* | USDA/FDA-cleared (2025); novel scalable bioreactor | Commercial |
| **Cultimate Foods** | 🇩🇪 Germany | *Cultured fat for plant-based meat* | €2.3M raised (2024); founded 2022 | Growth |
| **Ohayo Valley** | 🇺🇸 USA | *Cell-agriculture fat platform* | founded by early cultivated-meat tissue-engineering researcher | Growth |
| **CellulaREvolution** | 🇬🇧 UK | *Bovine adipose-derived stem cell spheroids* | 3D spheroid biofabrication for cultured fat | Unknown (in administration) |

---

## Tech stack and innovations

The stack is built around culturing fat cells as an ingredient rather than a structural meat substitute.

1. **Purpose-built fat-cell bioreactors (Purpose-Built Fat-Cell Bioreactors):**
   - bioreactor designs are engineered specifically around fat-cell culture economics rather than adapted from muscle-cell systems.
   - case: Mission Barns' novel bioreactor design is intended to lower the capital intensity that has slowed broader cultivated-meat scale-up.
2. **3D adipose spheroid biofabrication (3D Adipose Spheroid Biofabrication):**
   - differentiated adipose-derived stem cells are dynamically cultured as spheroids that serve as structural building blocks for cultured fat.
   - case: bovine adipose-derived stem cell spheroids have been demonstrated as a biofabrication building block in peer-reviewed research.
3. **Cross-species proof-of-concept culture (Cross-Species Proof-of-Concept Culture):**
   - fat-cell culture methods are being validated across multiple species' cell lines rather than a single target animal.
   - case: proof-of-concept cell-culture-based duck fat production has been demonstrated at laboratory scale alongside bovine and porcine work.

---

## Value chains and production pipelines

### Industrial pipeline of a cultivated fat ingredient (USDA/FDA joint pre-market review)

```
┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Cell line sourcing     │ ───> │ 2. Media formulation      │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Regulatory dossier     │ <─── │ 3. Bioreactor cultivation │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Ingredient blending    │ ───> │ 6. Retail launch          │
└───────────────────────────┘      └───────────────────────────┘
```

#### Stage 1: Cell line sourcing
Adipose-derived stem cells are isolated and banked from the target species (pig, cattle, duck).

#### Stage 2: Media formulation
A serum-free growth medium is formulated to expand and differentiate the fat-precursor cells.

#### Stage 3: Bioreactor cultivation
Cells or spheroids are cultured at scale in a purpose-built bioreactor designed around fat-cell economics.

#### Stage 4: Regulatory dossier
A joint USDA/FDA pre-market safety dossier is filed and reviewed, as completed by Mission Barns in 2025.

#### Stage 5: Ingredient blending
The cleared cultivated fat is blended into a hybrid meat or plant-based product to carry flavor and texture.

#### Stage 6: Retail launch
The finished product reaches retail, as targeted through a named grocery partner in the sector's first cleared case.

